Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 19, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Langerhans cell histiocytosis.

Kevin Bradford Hoover1, Daniel I Rosenthal, Henry Mankin

  • 1Musculoskeletal Radiology, Massachusetts General Hospital, Yawkey 6E 55 Fruit Street, Boston, MA 02114, USA. kbhoover@partners.org

Skeletal Radiology
|October 10, 2006
PubMed
Summary

Langerhans cell histiocytosis (LCH) is a rare disease with three syndromes sharing similar histology. This review covers LCH history, diagnosis, and treatment, emphasizing imaging for management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinguishing Epiphyseal Mass Lesions in Children, Adolescents, and Young Adults.

Radiographics : a review publication of the Radiological Society of North America, Inc·2025
Same author

To biopsy or not to biopsy: a retrospective review of presumed osteoid osteomas treated by radiofrequency ablation.

European radiology·2024
Same author

Elongated morphology of osteoid osteoma is associated with radiofrequency ablation failure in children.

Skeletal radiology·2024
Same author

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.

Oncotarget·2024
Same author

Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.

Scientific reports·2024
Same author

Preparing MSK radiologists of the future.

Skeletal radiology·2024

Area of Science:

  • Oncology
  • Pathology
  • Radiology

Background:

  • Langerhans cell histiocytosis (LCH) is a complex neoplastic proliferation of Langerhans cells.
  • It presents as three distinct clinical syndromes: eosinophilic granuloma, Hand-Schûller-Christian's disease, and Letterer-Siwe's disease, all with indistinguishable histology.
  • These syndromes vary in severity and organ involvement, from localized bone or lung lesions to multi-systemic disease.

Purpose of the Study:

  • To provide a comprehensive review of Langerhans cell histiocytosis (LCH).
  • To discuss the historical context, histological features, potential causes, and therapeutic strategies for LCH.
  • To highlight the critical role of radiographic findings and imaging techniques in diagnosing and managing LCH.

Main Methods:

  • Literature review of Langerhans cell histiocytosis (LCH).
  • Synthesis of information on LCH history, histology, etiology, and treatment.
  • Focus on radiographic manifestations and imaging modalities for LCH diagnosis and management.

Main Results:

  • LCH encompasses three syndromes with unified histology but diverse clinical presentations.
  • Radiographic findings and specific imaging modalities are crucial for accurate LCH diagnosis.
  • Understanding the spectrum of LCH is essential for effective patient management.

Conclusions:

  • Langerhans cell histiocytosis (LCH) requires a multidisciplinary approach integrating clinical, histological, and radiological data.
  • Effective management of LCH relies on accurate diagnosis through advanced imaging techniques.
  • Further research into LCH etiology and treatment optimization remains important.

Related Experiment Videos

Last Updated: Jul 19, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024